Download presentation
Presentation is loading. Please wait.
Published byRuth Small Modified over 9 years ago
1
Cytogenetic Insights in Mesenchymal Tumors Jonathan A. Fletcher, M.D. Pathology & Pediatrics Brigham & Women’s Hospital Dana-Farber Cancer Institute Harvard Medical School Boston, MA
2
How it is done!
3
Mince, then disaggregate cells by overnight treatment with collagenase
4
Disaggregated cells are plated as monolayer cultures on glass slides or in plastic flasks
5
All cultures are inspected daily, to determine whether tumor cells are growing, and when metaphase harvests should be performed
6
Leiomyoma: simple karyotype with t(12;14) HMGA2 (HMGIC)
7
Leiomyosarcoma: G-banded karyotype Complex! Clonal (arrows) and nonclonal aberrations
8
Example 1 Novel biologic mechanisms revealed through indentification of recurrent cytogenetic abnormalities in mesenchymal tumors
9
Aneurysmal Bone Cyst and the fusion fusion oncogene
11
Aneurysmal Bone Cyst Patients are generally < 20 years old Can recur locally, but do not become malignant “Primary ABC” have been generally regarded as nonneoplastic “Secondary ABC” associated with –osteoblastoma –chondroblastoma –giant cell tumor –osteosarcoma
12
Aneurysmal Bone Cyst 1999: Panoutsakopoulos et al. reported translocation t(16;17) in two ABC –neoplastic basis –recurrent oncogenic mechanism
13
Aneurysmal Bone Cyst 17p13 rearrangements in: –“solid variants” of ABC –soft-tissue ABC 25% of ABC have t(16;17) >25% of ABC have alternate translocations, involving 17p13, but not 16q22
14
Aneurysmal Bone Cyst t(16;17) –17p13 gene = USP6 (Ewing’s oncogene) –16q22 gene = CDH11 (aka “osteoblastic cadherin”) –promoter swapping between CDH11 and USP6 fusion of highly active CDH11 promoter to the 5’ UTR of USP6
15
Aneurysmal Bone Cyst Corroboration of “promoter swapping” mechanism in USP6 fusions TranslocationGene Promoter Swapping? t(9;17)osteomodulinYES t(17;17)COL1A1YES t(1;17)TRAP150YES t(3;17)ZNF9YES
16
Aneurysmal Bone Cyst What is the neoplastic cell? Mechanisms in secondary ABC?
17
USP6 oncogene in ABC spindle-cells
18
USP6 oncogene is not found in “secondary ABC” Secondary ABC Associated Chondroblastoma
19
USP6 or CDH11 Rearrangement in ABC 36 of 52 (69%) primary ABC 0 of 17 secondary ABC –giant cell tumor –osteoblastoma –chondroblastoma –fibrous dysplasia
20
USP6 is an evolutionarily-recent fusion of the PRC17 and USP32 genes (hominoid specific) USP6 PRC17USP32 TBC (rabGAP)UBP TBC (rabGAP)UBP >95% identity
21
USP6 Function: regulates endocytosis/destruction of activated proteins TBC (rabGAP)UBP - inactivates rab family members -rab function required for endocytosis of activated EGFR -UBP protease reverses ubiquitination - ?synergize with rabGAP function to inhibit endocytosis/proteolysis CDH 11
22
USP6 Expression Normal expression restricted to embryonic tissues and testis Neoplastic expression restricted to mesenchymal tumors: –2 of 2 osteoblastomas –1 of 4 myofibromas –1 of 3 Ewing’s sarcomas
23
Conclusions USP6 is overexpressed due to promoter swapping mechanisms in most primary ABC USP6 overexpression may stabilize oncogenic proteins USP6 is an evolutionarily recent gene, with likely relevance in sarcoma Useful models of mesenchymal tumor biology can come from unlikely places
24
Example 2 Smooth Muscle Tumors Use of cytogenetic clues to identify clinically-relevant biologic pathways in a genetically complex disease
25
Leiomyoma: simple karyotype with t(12;14) HMGA2 (HMGIC)
26
Leiomyosarcoma: G-banded karyotype
27
How do leiomyomas progress to malignancy? ???
28
Intravenous Leiomyomatosis Typical uterine leiomyoma Balanced t(12;14) Intravenous leiomyomatosis Unbalanced t(12;14) Partial trisomy 12q Paola Dal Cin Brad Quade Cynthia Morton t(12;14) with: partial trisomy 12q partial deletion 14q
29
Cytogenetic correlates for leiomyoma progression Vascular invasion –intravenous leiomyomatosis –unbalanced t(12;14) Increased proliferation –cellular leiomyoma –deletion 1p (also common in lms) Distant metastases –“benign metastasizing leiomyoma” –deletions of 19q and 22q
30
Pulmonary Chondroid Hamartoma (HMAG2 & HMGA1 oncogenes)
31
PCH: primitive mesenchymal, fat, chondroid
32
PCH: primitive mesenchymal, fat, chondroid, smooth muscle
33
Leiomyosarcoma/Leiomyoma: where do they start?
34
Is there proof that any sarcoma arises from a differentiated mesenchymal cell? osteo – bone chondro – cartilage lipo – fat leiomyo – smooth muscle rhabdo – skeletal muscle fibro – myofibroblast “GIST” – interstitial cell of Cajal NO
35
Andre Oliveira Paola Dal Cin Cynthia Morton Marisa Nucci Anette Duensing Chang-Jie Chen Nora Joseph Bryna Mcconarty Felicity Smith Lynn Yu Christopher Hubert Maureen Thyne Vicki Derr Stana Weremowicz George Demetri Christopher Fletcher Sam Singer Antonio Perez-Atayde Mark Gebhardt Andrew Rosenberg Julia Bridge
36
THANK YOU!!!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.